Construction of a Database for TMA
ConditionThrombotic Microangiopathies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorThe First Affiliated Hospital of Soochow University
About this trial
Information about patients was collected by reviewing the Hitech case system and telephone and outpatient follow-up, and the case database was constructed by Epidata software. The sample size is expected to be 200 cases, the participating hospital is the First Affiliated Hospital of Soochow University, and the study time frame is from Dec 1, 2022, to Nov 31, 2027. The observation indexes of the study include the basic information of patients' age and gender and the clinical-related data of thrombotic microangiopathy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
The patient has elevated lactate dehydrogenase to more than twice the baseline value, platelets less than 20 or decreased by more than 50% within 24 hours, and more than 2% of schistocytes visible on a peripheral blood smear. Alternatively, pathological sections show extensive micro thrombosis.
Disqualifiers
The investigator considers the subject unable or unwilling to cooperate with the study procedures.
Trial population
A total of 500 eligible TMA patients are to be collected for this project.
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
collection data
Other interventioncollection data
Treatment groups
500 Participants
are divided into 1 treatment groupGroup A: TMA1 intervention
Trial outcomes
Primary outcomes
1
Number of participants with stroke
Stroke was assessed with MRI imaging.
Time frame
5 years from the time of entering the database.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov